Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Diagnostic value of stool DNA testing for multiple markers of colorectal cancer and advanced adenoma: a meta-analysis.

Yang H, Xia BQ, Jiang B, Wang G, Yang YP, Chen H, Li BS, Xu AG, Huang YB, Wang XY.

Can J Gastroenterol. 2013 Aug;27(8):467-75. Review.

2.

Diagnostic value of aberrant gene methylation in stool samples for colorectal cancer or adenomas: a meta-analysis.

Yuan Y, Qu B, Yan J, Wang H, Yin L, Han Q.

Panminerva Med. 2015 Jun;57(2):55-64. Epub 2014 Sep 26. Review.

PMID:
25256821
3.

Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: a meta-analysis.

Luo YX, Chen DK, Song SX, Wang L, Wang JP.

Int J Clin Pract. 2011 Dec;65(12):1313-20. doi: 10.1111/j.1742-1241.2011.02800.x. Review.

PMID:
22093539
4.

Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.

Lidgard GP, Domanico MJ, Bruinsma JJ, Light J, Gagrat ZD, Oldham-Haltom RL, Fourrier KD, Allawi H, Yab TC, Taylor WR, Simonson JA, Devens M, Heigh RI, Ahlquist DA, Berger BM.

Clin Gastroenterol Hepatol. 2013 Oct;11(10):1313-8. doi: 10.1016/j.cgh.2013.04.023. Epub 2013 Apr 29.

PMID:
23639600
5.

DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.

Bosch LJ, Oort FA, Neerincx M, Khalid-de Bakker CA, Terhaar sive Droste JS, Melotte V, Jonkers DM, Masclee AA, Mongera S, Grooteclaes M, Louwagie J, van Criekinge W, Coupé VM, Mulder CJ, van Engeland M, Carvalho B, Meijer GA.

Cancer Prev Res (Phila). 2012 Mar;5(3):464-72. doi: 10.1158/1940-6207.CAPR-11-0315. Epub 2011 Dec 1.

6.

Accuracy of early detection of colorectal tumours by stool methylation markers: a meta-analysis.

Zhang H, Qi J, Wu YQ, Zhang P, Jiang J, Wang QX, Zhu YQ.

World J Gastroenterol. 2014 Oct 14;20(38):14040-50. doi: 10.3748/wjg.v20.i38.14040. Review.

7.

The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia.

Ahlquist DA, Taylor WR, Mahoney DW, Zou H, Domanico M, Thibodeau SN, Boardman LA, Berger BM, Lidgard GP.

Clin Gastroenterol Hepatol. 2012 Mar;10(3):272-7.e1. doi: 10.1016/j.cgh.2011.10.008. Epub 2011 Oct 20.

8.

A combination of faecal tests for the detection of colon cancer: a new strategy for an appropriate selection of referrals to colonoscopy? A prospective multicentre Italian study.

Parente F, Marino B, Ilardo A, Fracasso P, Zullo A, Hassan C, Moretti R, Cremaschini M, Ardizzoia A, Saracino I, Perna F, Vaira D.

Eur J Gastroenterol Hepatol. 2012 Oct;24(10):1145-52. doi: 10.1097/MEG.0b013e328355cc79.

PMID:
22735608
9.

Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.

Wu CW, Ng SC, Dong Y, Tian L, Ng SS, Leung WW, Law WT, Yau TO, Chan FK, Sung JJ, Yu J.

Clin Cancer Res. 2014 Jun 1;20(11):2994-3002. doi: 10.1158/1078-0432.CCR-13-1750. Epub 2014 Apr 1.

10.

MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.

Chen L, Cui Z, Liu Y, Bai Y, Lan F.

Clin Lab. 2015;61(8):1101-8. Review.

PMID:
26427157
11.

Novel methylation panel for the early detection of colorectal tumors in stool DNA.

Azuara D, Rodriguez-Moranta F, de Oca J, Soriano-Izquierdo A, Mora J, Guardiola J, Biondo S, Blanco I, Peinado MA, Moreno V, Esteller M, Capellá G.

Clin Colorectal Cancer. 2010 Jul;9(3):168-76. doi: 10.3816/CCC.2010.n.023.

PMID:
20643622
12.

Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.

Shan L, Ji Q, Cheng G, Xia J, Liu D, Wu C, Zhu B, Ding Y.

Cancer Biomark. 2015;15(1):47-56. doi: 10.3233/CBM-140437. Review.

PMID:
25524942
13.

The diagnostic value of DNA hypermethylation in stool for colorectal cancer: a meta-analysis.

Qian LY, Zhang W.

J Cancer Res Ther. 2014 Dec;10 Suppl:287-91. doi: 10.4103/0973-1482.151534.

14.

Next-generation stool DNA test accurately detects colorectal cancer and large adenomas.

Ahlquist DA, Zou H, Domanico M, Mahoney DW, Yab TC, Taylor WR, Butz ML, Thibodeau SN, Rabeneck L, Paszat LF, Kinzler KW, Vogelstein B, Bjerregaard NC, Laurberg S, Sørensen HT, Berger BM, Lidgard GP.

Gastroenterology. 2012 Feb;142(2):248-56; quiz e25-6. doi: 10.1053/j.gastro.2011.10.031. Epub 2011 Nov 4.

15.

Diagnostic Value of Fecal MicroRNAs for Colorectal Cancer: a Meta-Analysis.

Wang C, Zhao K, Rong Q.

Clin Lab. 2015;61(12):1845-53.

PMID:
26882806
16.

Analysis of DNA methylation in bowel lavage fluid for detection of colorectal cancer.

Harada T, Yamamoto E, Yamano HO, Nojima M, Maruyama R, Kumegawa K, Ashida M, Yoshikawa K, Kimura T, Harada E, Takagi R, Tanaka Y, Aoki H, Nishizono M, Nakaoka M, Tsuyada A, Niinuma T, Kai M, Shimoda K, Shinomura Y, Sugai T, Imai K, Suzuki H.

Cancer Prev Res (Phila). 2014 Oct;7(10):1002-10. doi: 10.1158/1940-6207.CAPR-14-0162. Epub 2014 Aug 19.

17.

Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.

Li F, Tie R, Chang K, Wang F, Deng S, Lu W, Yu L, Chen M.

BMC Cancer. 2012 Jun 19;12:258. doi: 10.1186/1471-2407-12-258.

18.
19.

Diagnostic precision of magnetic resonance imaging for preoperative prediction of the circumferential margin involvement in patients with rectal cancer.

Purkayastha S, Tekkis PP, Athanasiou T, Tilney HS, Darzi AW, Heriot AG.

Colorectal Dis. 2007 Jun;9(5):402-11.

PMID:
17504336
20.

Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel.

Ahlquist DA, Skoletsky JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE, Thibodeau SN, Shuber AP.

Gastroenterology. 2000 Nov;119(5):1219-27.

PMID:
11054379

Supplemental Content

Support Center